Summary for Clinicians: Clinical Practice Guideline on Home Oxygen Therapy for Adults with Chronic Lung Disease

Home oxygen therapy is prescribed to over 1.5 million Americans at an annual cost of more than $2.9 billion, with cost increasing by 12–13% per year. An evidence-based clinical practice guideline on home oxygen therapy for adults with chronic lung disease was published in 2020 by a multidisciplinary panel of experts and a patient representative. A comprehensive systematic review of the literature with resulting data synthesis was performed to address the key questions for clinical recommendations. This summary provides key takeaway points for practicing clinicians.

Target Audience

Pulmonologists, critical care specialists, translational researchers, and clinicians

Learning Objectives

At the conclusion of this activity, learners should be able to:

  • Differentiate between different types of home oxygen therapy
  • Evaluate and identify patients with chronic obstructive pulmonary disease and interstitial lung disease who require ambulatory and long-term oxygen therapy
  • Provide essential education on home oxygen therapy for patients and their carers 
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The American Thoracic Society designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
Publication Date: 
09/01/2021
Credit Expires: 
09/01/2023
Rating: 
0

Accreditation Statement

The American Thoracic Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Disclosure Declaration

Article Authorship Disclosures (as submitted to the ATS prior to article publication date)

Susan S. Jacobs, R.N., M.S. (Stanford University, Stanford, CA, USA) reported no relevant financial relationships.

David J. Lederer, M.D., M.S. (Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA) reported being a full-time employee of Regeneron Pharmaceuticals, Inc., and holding Regeneron stock and stock options.

Jerry A. Krishnan, M.D., Ph.D. (University of Illinois at Chicago, Chicago, IL, USA) reported receiving grants from ResMed/Inogen.

Anne E. Holland, P.T., Ph.D. (Alfred Health and Monash University, Melbourne, Victoria, Australia) reported receiving equipment loans for clinical trials from Air Liquide, and logistics support for clinical trial from BOC Healthcare.

Joseph K. Ruminjo, M.D. (American Thoracic Society, New York, NY, USA) reported no relevant financial relationships.

Carey C. Thomson, M.D., M.P.H. (Harvard Medical School, Boston, MA, USA) reported no relevant financial relationships.

Off-Label Usage Disclosure

None

Disclosures of AnnalsATS CME Planners

The Annals of the American Thoracic Society (AnnalsATS) original research, commentaries, reviews, and educational content of interest to clinicians and clinical investigators in pediatric and adult pulmonary and sleep medicine and medical critical care. The scope of the journal encompasses content that is applicable to clinical practice, the formative and continuing education of clinical specialists, and the advancement of public health.

The publication of articles that meet these goals by itself is only one step in a multi-step process for the translation of evidence-based improvements in are to clinical practice. Testing for CME credit is designed to function as a next step in the process. This is accomplished through a series of questions written by the author(s) to test that readers have the tools needed to translate recommendations for diagnostic and therapeutic clinical care into clinical practice. Members of the AnnalsATS editorial board review these questions and edit these questions for clarity, educational content, and the quality of the evidence supporting the response to the question.

AnnalsATS CME Planners

Alan M. Fein, M.D.
Podcast Editor, AnnalsATS
Dr. Fein reported that he has no financial relationships with ineligible companies.

Constantine Manthous, M.D.
Associate Editor, AnnalsATS
Dr. Manthous reported that he has no financial relationships with ineligible companies.

Gregory A. Schmidt, M.D.
Editorial Board, AnnalsATS
Dr. Schmidt reported payments for writing a textbook on critical care medicine (McGraw-Hill) and for writing contributions for UptoDate.

Instructions to Receive Credit

To receive credit for this journal article:

  1. Read the journal article. Keep track of how long it takes you to read it.
  2. Once you open the article, the Post-Test becomes available. After reading the article, answer the post-test questions. You must answer all questions correctly to earn credit. You may take the test as many times as you like.
  3. Once you pass the Post-Test, the Evaluation becomes available. Answer all the evaluation questions.
  4. Once you complete the evaluation, select the amount of credit to receive based on the time it took you to read the article.
  5. You can view, save and print your Certificate by pressing the Certificate button.
  6. To review the credits you've earned in this system and reprint certificates, go to the My Learning drop-down list. Then select Transcript.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    The American Thoracic Society designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
Please login or register to take this course.

 

To start this learning activity, press the Take Activity button. Then follow the on-screen instructions.

The system keeps track of your progress. If you close the activity and resume it later, it will re-start where you left off.